Hot Topics in Atopic Dermatitis

In this video interview, Benjamin N. Ungar, MD, assistant professor of dermatology and director of the Rosacea & Seborrheic Dermatitis Clinic at Mount Sinai, discussed:

• current JAK inhibitors approved to treat atopic dermatitis;
• positioning different JAK inhibitors;
• using JAKs in combination with other therapies;
• “keeping a close eye on” risks associated with JAK inhibitor use in other diseases as this treatment becomes used more commonly in AD;
• how JAK inhibitors impacted the treatment landscape; and
• considerations for future research in this area.